162 related articles for article (PubMed ID: 38385332)
1. Design, synthesis, and evaluation of cyclic C7-bridged monocarbonyl curcumin analogs containing an
Gan X; Wu Y; Zhu M; Liu B; Kong M; Xi Z; Li K; Wang H; Su T; Yao J; Khushafah F; Yi B; Wang J; Li W; Wu J
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2314233. PubMed ID: 38385332
[TBL] [Abstract][Full Text] [Related]
2. Discovery of cinnamylaldehyde-derived mono-carbonyl curcumin analogs as anti-gastric cancer agents via suppression of STAT3 and AKT pathway.
Chen X; Zhang P; Zhang H; Ma X; Zhang Y; Wu Y; Jin K; Wang J; Wu J
Bioorg Chem; 2024 May; 146():107306. PubMed ID: 38531150
[TBL] [Abstract][Full Text] [Related]
3. Design, green synthesis, antioxidant activity screening, and evaluation of protective effect on cerebral ischemia reperfusion injury of novel monoenone monocarbonyl curcumin analogs.
He W; Wang J; Jin Q; Zhang J; Liu Y; Jin Z; Wang H; Hu L; Zhu L; Shen M; Huang L; Huang S; Li W; Zhuge Q; Wu J
Bioorg Chem; 2021 Sep; 114():105080. PubMed ID: 34225164
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Cytotoxic Evaluation of Monocarbonyl Analogs of Curcumin as Potential Anti-Tumor Agents.
Pan Z; Chen C; Zhou Y; Xu F; Xu Y
Drug Dev Res; 2016 Feb; 77(1):43-9. PubMed ID: 26846154
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological Evaluations of Monocarbonyl Curcumin Inspired Pyrazole Analogues as Potential Anti-Colon Cancer Agent.
Min Z; Zhu Y; Hong X; Yu Z; Ye M; Yuan Q; Hu X
Drug Des Devel Ther; 2020; 14():2517-2534. PubMed ID: 32636614
[TBL] [Abstract][Full Text] [Related]
6. Da0324, an inhibitor of nuclear factor-κB activation, demonstrates selective antitumor activity on human gastric cancer cells.
Jin R; Xia Y; Chen Q; Li W; Chen D; Ye H; Zhao C; Du X; Shi D; Wu J; Liang G
Drug Des Devel Ther; 2016; 10():979-95. PubMed ID: 27042000
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antimalarial activity and cytotoxic potential of new monocarbonyl analogues of curcumin.
Manohar S; Khan SI; Kandi SK; Raj K; Sun G; Yang X; Calderon Molina AD; Ni N; Wang B; Rawat DS
Bioorg Med Chem Lett; 2013 Jan; 23(1):112-6. PubMed ID: 23218718
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and preliminary evaluation of curcumin analogues as cytotoxic agents.
Zhang Q; Zhong Y; Yan LN; Sun X; Gong T; Zhang ZR
Bioorg Med Chem Lett; 2011 Feb; 21(3):1010-4. PubMed ID: 21215629
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, in vitro and in silico evaluation of anti-colorectal cancer activity of curcumin analogues containing 1,3-diphenyl-1H-pyrazole targeting EGFR tyrosine kinase.
Doan NQH; Nguyen NTK; Nguyen NB; Tran TT; Tran QN; Truong TN
Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130414. PubMed ID: 37331408
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents.
Adams BK; Ferstl EM; Davis MC; Herold M; Kurtkaya S; Camalier RF; Hollingshead MG; Kaur G; Sausville EA; Rickles FR; Snyder JP; Liotta DC; Shoji M
Bioorg Med Chem; 2004 Jul; 12(14):3871-83. PubMed ID: 15210154
[TBL] [Abstract][Full Text] [Related]
11. Monocarbonyl Analogs of Curcumin with Potential to Treat Colorectal Cancer.
Clariano M; Marques V; Vaz J; Awam S; Afonso MB; Jesus Perry M; Rodrigues CMP
Chem Biodivers; 2023 Mar; 20(3):e202300222. PubMed ID: 36807727
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and anticancer evaluation of long-chain alkoxylated mono-carbonyl analogues of curcumin.
Weng Q; Fu L; Chen G; Hui J; Song J; Feng J; Shi D; Cai Y; Ji J; Liang G
Eur J Med Chem; 2015 Oct; 103():44-55. PubMed ID: 26318057
[TBL] [Abstract][Full Text] [Related]
13. Novel Curcumin Inspired Antineoplastic 1-Sulfonyl-4-Piperidones: Design, Synthesis and Molecular Modeling Studies.
Fawzy NG; Panda SS; Fayad W; El-Manawaty MA; Srour AM; Girgis AS
Anticancer Agents Med Chem; 2019; 19(8):1069-1078. PubMed ID: 30961509
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines.
Mandalapu D; Saini KS; Gupta S; Sharma V; Yaseen Malik M; Chaturvedi S; Bala V; Hamidullah ; Thakur S; Maikhuri JP; Wahajuddin M; Konwar R; Gupta G; Sharma VL
Bioorg Med Chem Lett; 2016 Sep; 26(17):4223-32. PubMed ID: 27496212
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and preliminary in-vitro studies of novel boronated monocarbonyl analogues of Curcumin (BMAC) for antitumor and β-amiloyd disaggregation activity.
Azzi E; Alberti D; Parisotto S; Oppedisano A; Protti N; Altieri S; Geninatti-Crich S; Deagostino A
Bioorg Chem; 2019 Dec; 93():103324. PubMed ID: 31585269
[TBL] [Abstract][Full Text] [Related]
16. Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents.
Liang G; Shao L; Wang Y; Zhao C; Chu Y; Xiao J; Zhao Y; Li X; Yang S
Bioorg Med Chem; 2009 Mar; 17(6):2623-31. PubMed ID: 19243951
[TBL] [Abstract][Full Text] [Related]
17. Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy.
Zhang W; Guo J; Li S; Ma T; Xu D; Han C; Liu F; Yu W; Kong L
Sci Rep; 2017 Apr; 7():46352. PubMed ID: 28397855
[TBL] [Abstract][Full Text] [Related]
18. Antitumor agents 247. New 4-ethoxycarbonylethyl curcumin analogs as potential antiandrogenic agents.
Lin L; Shi Q; Su CY; Shih CC; Lee KH
Bioorg Med Chem; 2006 Apr; 14(8):2527-34. PubMed ID: 16427289
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of asymmetric curcuminoid analogs as potential anticancer agents that downregulate NF-κB activation and enhance the sensitivity of gastric cancer cell lines to irinotecan chemotherapy.
Qiu P; Zhang S; Zhou Y; Zhu M; Kang Y; Chen D; Wang J; Zhou P; Li W; Xu Q; Jin R; Wu J; Liang G
Eur J Med Chem; 2017 Oct; 139():917-925. PubMed ID: 28881286
[TBL] [Abstract][Full Text] [Related]
20. Preparation, Characterization and In Vitro Biological Evaluation of Novel Curcumin Derivatives as Cytotoxic and Apoptosis-Inducing Agents.
Arjomandi OK; Almasi S; Hosseinzadeh L; Kavoosi M; Adibi H
Anticancer Agents Med Chem; 2021; 21(10):1309-1322. PubMed ID: 33006540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
